Treatment for Hemophilia
Links shared publicly online about this topic
Tulane researcher finds treatment for hemophilia - The Tulane Hullabaloo : News
thehullabaloo.com — “Tulane professor Cindy Leissinger led an international research team that has discovered that FEIBA, a drug cocktail currently used to treat bleeding events in certain severe hemophilia patients, can also be used to prevent bleeding events before they occur.” View full resource at thehullabaloo.com
Most Recently Shared on November 18, 2011 at 10:45 pm By:
Susan Scroggins - vWD Arkansas Patient Advocate and Active Health Library
Tulane researcher finds treatment for hemophilia http://t.co/mgeYnUXM via @tweetmeme
Pfizer Receives FDA Approval For Prefilled Dual-Chamber Syringe For Use In The Treatment Of Hemophilia A
medicalnewstoday.com — “Pfizer Inc.has announced that the U.S. Food and Drug Administration (FDA) has granted approval of the use of a Prefilled Dual-Chamber Syringe for administration of XYNTHA® Antihemophilic Facto” View full resource at medicalnewstoday.com
Most Recently Shared on August 10, 2010 at 12:00 pm By:
Pfizer Receives FDA Approval For Prefilled Dual-Chamber Syringe For Use In The Treatment Of Hemophilia A http://mnt.to/3H9R
European Commission grants Ipsen's OBI-1 orphan drug status for treatment of hemophilia
news-medical.net — “Ipsen announced today that the European Commission has granted orphan drug status for OBI-1 for the treatment of hemophilia. Expected to enter pivotal clinical trials before the end of this year, OBI-1 is designed to treat individuals with hemophilia who have developed inhibitory antibodies (inhibitors) against human Factor VIII (hFVIII).” View full resource at news-medical.net
Most Recently Shared on October 20, 2010 at 5:11 pm By:
News-Medical.Net Health News and Oncology
Oncology News: European Commission grants Ipsen's OBI-1 orphan drug status for treatment of hemophilia: Ipsen anno... http://bit.ly/9lFYeN
Pfizer Receives FDA Approval For Prefilled Dual-Chamber Syringe For Use In The Treatment Of Hemophilia A - QualityPoint Technologies
qualitypointtech.net — “Pfizer Inc.has announced that the U.S. Food and Drug Administration (FDA) has granted approval of the use of a Prefilled Dual-Chamber Syringe for administration of XYNTHA Antihemophilic Factor (Recombinant) Plasma/Albumin-Free to hemophilia A patients. XYNTHA is a recombinant factor VIII product indicated for both the control and prevention of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency or classic hemophilia) and for surgical prophylaxis in patients with he” View full resource at qualitypointtech.net
Most Recently Shared on August 10, 2010 at 11:57 am By:
Pfizer Receives FDA Approval For Prefilled Dual-Chamber Syringe For Use In The Treatment Of Hemophilia A: Pfizer I... http://bit.ly/bK0qIB
Early Safety Results Promising for Phase I/II Trial of Gene Therapy Treatment of Hemophilia B
newswise.com — “Investigators report no evidence of toxicity in the four hemophilia B patients enrolled to date in a gene therapy trial using a vector under development at St. Jude Children--™s Research Hospital and UCL (University College London) to correct the inherited bleeding disorder.” View full resource at newswise.com
Most Recently Shared on December 6, 2010 at 5:22 pm By:
newswise Health Communicator and Health News
Early Safety Results Promising for Phase I/II Trial of Gene Therapy Treatment of Hemophilia B: Investigators rep... http://bit.ly/i9h1bw
Early Safety Results Promising for Phase I/II Trial of Gene Therapy Treatment of Hemophilia B - Drugs.com MedNews
drugs.com — “Vector-gene combination developed at St. Jude Children s Research Hospital and UCL is central to latest clinical trial of gene therapy as a possible tool to pro” View full resource at drugs.com
Most Recently Shared on December 7, 2010 at 9:07 pm By:
Drugs and Devices OW OW Health
Early Safety Results Promising for Phase I/II Trial of Gene Therapy Treatment of Hemophilia B: Vector-gene... http://bit.ly/gIu31v #drug
FDA Approves 8 Mg Vial Of NovoSeven® RT For The Treatment Of Hemophilia A Or B With Inhibitors And Enhanced Shelf Life For All Vial Sizes
medicalnewstoday.com — “Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has approved NovoSeven® RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) in an 8 mg vial size, making” View full resource at medicalnewstoday.com
Most Recently Shared on August 11, 2010 at 2:00 pm By:
FDA Approves 8 Mg Vial Of NovoSeven® RT For The Treatment Of Hemophilia A Or B With Inhibitors And Enhanced Shelf ... http://mnt.to/3HdM
Baxter U.S. - Baxter Initiates Phase I Clinical Trial of Longer-Acting Recombinant FVIII Treatment for Hemophilia A
baxter.com — “Baxter Initiates Phase I Clinical Trial of Longer-Acting Recombinant FVIII Treatment for Hemophilia A” View full resource at baxter.com
Most Recently Shared on January 5, 2012 at 3:56 pm By:
Baxter Initiates Phase I Clinical Trial of Longer-Acting Recombinant FVIII Treatment for Hemophilia A. http://t.co/3qimbHWV
Pediatric Hemophilia - Symptoms, Tests, Treatment
childrenshospital.org — “Hemophilia is a blood clotting problem in which a simple cut can cause uncontrollable bleeding because the body lacks blood clotting proteins. Each year, about 400 children with hemophilia are born. At Children's Hospital Boston, the Boston Hemophilia Center will provide hemophilia support through a comprehensive care model.” View full resource at childrenshospital.org
Most Recently Shared on March 17, 2012 at 7:30 pm By:
Children's Hospital Hospital and Children's Hospital
Did you know? There are 18,000 people living with hemophilia in the United States. More facts: http://t.co/3kZaYBeg
Pediatric Hemophilia - Symptoms, Tests, Treatment
childrenshospital.org — “Hemophilia is a blood clotting problem in which a simple cut can cause uncontrollable bleeding because the body lacks blood clotting proteins. Each year, about 400 children with hemophilia are born. At Children's Hospital Boston, the Boston Hemophilia Center will provide hemophilia support through a comprehensive care model.” View full resource at childrenshospital.org
Most Recently Shared on March 12, 2012 at 7:30 pm By:
Children's Hospital Hospital and Children's Hospital
Each year, about 400 children are born with hemophilia. Do you know what it is? http://t.co/N6gQxcoW
Boston Hemophilia Center | Facebook
facebook.com — “Boston Hemophilia Center - As a federally funded hemophilia treatment center, the Boston Hemophilia Center provides comprehensive care to people with hemophilia and other bleeding disorders. - General Information: The Boston Hemophilia Center is a combined program of Children's Hospital Boston and Brigham and Women's Hospital. We care for more than 400 children and adults with congenital bleeding disorders. - Mission: To postitively impact the health, life-style and long-term well-bein” View full resource at facebook.com
Most Recently Shared on March 14, 2012 at 7:30 pm By:
Children's Hospital Hospital and Children's Hospital
Show your support! Join our Boston Hemophilia Center page on Facebook: http://t.co/2iWBFlpn
Harnessing The Power Of Plants To Fight Hemophilia
medicalnewstoday.com — “Hemophilia, a disease linked with legends of European monarchs, frail heirs and one flamboyant charlatan called Rasputin, still afflicts many people today.And the very treatments that ca” View full resource at medicalnewstoday.com
Most Recently Shared on March 31, 2010 at 5:09 pm By:
Harnessing The Power Of Plants To Fight Hemophilia http://mnt.to/3zGW #vaccines #immunesystem
Hemophilia B - Single Gene Therapy Treatment Offers Significant Improvement
medicalnewstoday.com — “Patients with hemophilia B experienced considerable improvements and fewer injections with clotting factor to reduce bleeding after receiving just one treatment with gene therapy, researchers from” View full resource at medicalnewstoday.com
Most Recently Shared on December 10, 2011 at 8:05 pm By:
Hemophilia B - Single Gene Therapy Treatment Offers Significant Improvement http://t.co/1RVC3T8U #blood #hematology
CDC Features - WORLD HEMOPHILIA DAY, 4/17/11 - Hemophilia: Signs, Symptoms and Treatment - Digg
digg.com — “April 17th is World Hemophilia Day. Learn how to recognize the hemophilia symptoms and where to receive comprehensive treatment.” View full resource at digg.com
Most Recently Shared on April 15, 2011 at 5:56 pm By:
SNAPPIN' MINISTRIES Patient Advocate
CDC Features - WORLD HEMOPHILIA DAY, 4/17/11 - #Hemophilia: Signs, Symptoms and Treatment http://t.co/Kb6FKaC via @Digg
CSL Behring Marks World Hemophilia Day With Factor IX Donation To World Federation Of Hemophilia
medicalnewstoday.com — “Hemophilia B patients in the developing world will benefit from a recent donation of 1 million international units (IU) of factor IX medication made by CSL Behring to the World Federation of Hemop” View full resource at medicalnewstoday.com
Most Recently Shared on April 17, 2010 at 1:05 pm By:
CSL Behring Marks World Hemophilia Day With Factor IX Donation To World Federation Of Hemophilia http://mnt.to/3Bpr #blood #hematology
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Susan Scroggins - vWD Arkansas
Mom of two kids diagnosed with von Willebrand disease. Looking to give & get support from other's with vWD - all types welcome.
-
MNT Blood
The latest blood and hematology news published daily. Articles from research centers, universities and prestigious journals.
-
News-Medical.Net
Stay up to date with the latest Oncology news and research via News-Medical.Net
Advertisement
